Value proposition

In Silico Clinical Trials: not just the evidence, the mechanisms behind

Anaxomics is AI biotech company that use cutting-edge technologies based on Systems Biology to overcome challenges in drug discovery and development process. We’re specialized in In Silico Clinical Trials, which offer a highly efficient way to optimize clinical trials.

Our proprietary technology, Therapeutic Performance Mapping Systems Technology (TPMS), enables to build mathematical models that elucidate the mechanisms of action of drugs and identify biomarkers to monitor in the trials. With TPMS, we also provide early profiling of safety issues and off-target effects, helping to optimize clinical trials and speed up the drug development process.

Our team of experts is dedicated to advancing scientific knowledge and bringing innovative solutions to pharmaceutical and biotech companies and researchers worldwide. We are delighted to offer our services in both fee-for-service and collaborative arrangements, including initiatives such as H2020 and RIS3CAT, to meet the unique needs of our clients and partners while delivering high-quality results.

We have a proven track record of success, with numerous successful projects and collaborations under our belt. Our flexible working arrangements and exceptional service ensure that we achieve success in all of our projects.

Our services include:
- In Silico Clinical Trials (ISCT)
- Elucidating mechanisms of action
- Real World Evidence (RWE) studies
- Identify biomarkers for diagnosis, prognosis, and treatment
- Identify new indication of existing drugs: Repurposing
- Identify combinatorial therapies
- Identify therapeutic targets and off-targets
- Early profiling of safety issues and off-target effects

At Anaxomics Biotech, we are committed to improving the drug discovery and development process, paving the way for more effective and efficient treatments for patients worldwide.


In Silico Clinical Trial , Artificial Intelligence, Systems Biology, drug discovery, Real World Evidence, Mechanism of Action, Biomarkers, precision medicine, data science, Combinatory Therapies, New Indications, Safety prediction, Machine Leraning, repurposing, and Real World Evidence